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Abstract
Background. Polyacrylonitrile (PAN, AN69®) dialysis
membranes have been shown to improve the outcome
of critically ill patients. Factor D is an essential enzyme
of the alternative pathway of complement and is
increased during renal failure. On the other hand
the contact of blood with biomaterials activates the
complement cascade through the alternative pathway.
PAN niters adsorb factor D which looses its enzymatic
activity whilst bound to the membrane [1]; the comple-
ment alternative pathway function of serum exposed
to PAN filters is greatly diminished and restored after
addition of purified factor D [1]. The aim of our study
was to measure the time course of factor D adsorption
and its blood concentration during CVVH in critically
ill patients with acute renal failure.
Methods. We studied seven critically ill patients with
ARF before, during and after continuous veno-venous
haemofiltration (CWH) with AN69.
Results. There was a rapid decrease of factor D levels
to 62(±6%) of the pre-CWH value during the first
2 h, which continued to 51 (±7.3%) after 12 h; at 24 h
there was a slight rise to 62+ 12%. Sequential use of
Polyacrylonitrile (AN69®) filters lowered factor D
levels below the normal plasma concentration in three
patients, thus producing a state of factor D depletion.
Conclusion. The significant reduction of factor D levels
during CWH with PAN filters suggests that frequent
changes of PAN filters may reduce alternative pathway
function by lowering factor D levels. CVVH (as
opposed to intermittent dialysis) with PAN membranes
may further improve the outcome of critically ill
patients.
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Introduction
Recently, a prospective randomized study indicated that
the outcome of critically ill patients was improved by
biocompatible membranes made of polyacrylonitrile
(AN69®) during discontinuous haemodialysis, as com-
pared with cuprophane membranes [2]. The adsorptive
properties of PAN membrane are crucial to determine
its biocompatibility with regard to complement activa-
tion. In particular, the anaphylatoxins C3a and C5a, as
well as complement factor D are adsorbed very effici-
ently by AN69® [1]. Factor D is the rate limiting
enzyme of the alternative pathway of complement (AP)
activation. Its plasma concentration is low in normal
individuals (2ug/ml), but is increased approximately
ten-fold in patients with end-stage renal failure, due to
a decreased renal catabolism [3,4]. The increased level
of factor D in patients with renal failure is directly
responsible for an enhanced activity of the AP, which
may be detrimental [5]. Factor D removal by adsorption
on PAN (AN69®) has been shown to be substantial,
with 80% reduction of plasma levels after regular
haemodialysis sessions [1]. Thus PAN membranes have
the potential to deplete factor D from the circulation
and possibly down regulate complement activation. We
studied the efficiency of factor D removal by AN69®
filters during continuous veno-venous haemofiltration
in critically ill patients with acute renal failure.
Methods
Seven critically ill patients with ARF requiring CWH were
studied (mean age: 62.1 years; range: 41-81). The aetiologies
of ARF were septic shock (n = 3), haemodynamic insuffi-
ciency due to cardiac failure (n = 3), and hepatorenal syn-
drome (n= 1). The hollow-fibre dialysis filters were replaced
after clotting or because of insufficient ultrafiltration rate
(<700ml/h). CWH was performed with blood flows fixed
at 250 ml/min. AN69® filters (copolymers of polyacrylonitrile
and sodium metallylsulfonate, Hospal, Lyon, France) had
an effective surface of 0.6 or 0.9 m2 (Multiflow 60 or 100,
respectively), the mean ultrafiltration rates were 1000 cc/h
© 1996 European Dialysis and Transplant Association-European Renal Association
118 Y. Gasche el al.
for the eight 0.6 m2 and 1500 cc/h for the six 0.9 m2 filters
studied; in addition, filters made of polyamide fibres
(Gambro, FH66, Hechingen, Germany) were also studied
and used as controls. Their effective surface of ultrafiltration
was 0.6 m2 and the mean ultrafiltration rate was 1500 cc/h
for the five filters studied.
Blood samples were collected on EDTA before starting
CWH and during the procedure at 15min., 1, 2, 4, 6, 12
and 24 h in the arterial and venous lines. Plasma was
immediately separated by centrifugation at 1500 g for 10 min
at 4°C. Ultrafiltrate was collected simultaneously without
additive. All samples were stored at -80°C. Factor D
haemolytic activity was determined as previously described
[3]. IgM levels were measured by laser nephelometry and
used to correct results for possible changes in haemoconcen-
tration during the CWH procedure.
No patient received whole blood or plasma during the
studies.
The results are given as mean (± standard error of the
mean) and statistical analysis are performed using analysis
of variance (ANOVA).
Results
The levels of factor D before CWH differed from










Fig. 1. A. Mean (±SEM) factor D change in percent of pre-CWH
ratios with 14 AN69 filters at 2 h, 4 h, 6 h, 12 h, and 24 h of CWH.
ANOVA for repeated measures between pre-CWH ratio and 2 h,
4h, 6h, 12 h, 24 h ratios: */><0.0001; **/><0.0026. B. Mean
(±SEM) factor D extraction ratios (pre-filter—post-filter/pre-filter
samples) at 15 min, 1 h, 2h, 4h, 6 h, 12 h and 24 h of CWH.
duration of renal failure (mean: 7 ug/ml; ranges:
2.3-11.1 ug/ml). CWH with PAN membranes was
followed by an immediate fall in the levels of factor D
in all patients. The drop was fast during the first two
hours and slower over the following 10 h. In patients
in whom the dialysis filters were not changed (n = 2),
factor D increased slightly over the next 12 h
(Figure 1A). The extraction of factor D by AN69
filters was calculated from the pre- and post-filter
difference. As expected from the changes in factor D
levels, the extraction was highest during the first hours,
then levelled off during the period of time studied
(Figure IB). There was still a measurable extraction
at 24 h, at a time of rising factor D levels in plasma.
Interestingly it was possible in three patients to lower
factor D concentrations below the mean values of
normal individuals (2 ug/ml) by using two PAN filters
sequentially, as illustrated for one patient in Figure 2.
Factor D increased immediately upon interruption of
haemofiltration even for the short period of time
required to change from one PAN filter to the next
(Figures 2 and 3). The immediate effects of CWH
with PAN were also evident when the control poly-
amide filters were used either before or after the PAN
membranes (Figures 2 and 3). No factor D was found
in the ultrafiltrate of PAN filters during the first 12 h
Fig. 2. Plasma levels of factor D (ug/ml) during CWH with small




Fig. 3. Plasma levels of factor D (ugml) during CWH with poly-
amide and large AN69 (AN69*) filters in patient 2.
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and only minimal amounts (10-20 |ig/l) could be
detected at 24 h. Four PAN membranes (2 small and
2 large) were washed immediately after use with 15 mM
NaCl, followed by elution of membrane associated
proteins with 2M NaCl [1].
Quantitative analysis indicated that 52 and 53 mg of
factor D were eluted from two 0.6 m2 filters, and 66
and 60 mg from two 0.9 m2 filters, respectively. No
factor D could be eluted from polyamide membranes
using similar conditions.
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have been shown to trigger TNF and IL1 release by
mononuclear cells [10].
In clinical situations such as sepsis with ARF, the
PAN membrane should be viewed as a drug, suitable
for a definite time, especially if a series of noxious
mediators in plasma were down regulated, e.g. comple-
ment and cytokines.
Whether CWH with PAN is superior to intermittent
dialysis in the outcome of critically ill patients remains
to be studied. If so, frequent changes of PAN filters,
or new devices with similar biomaterials may reveal
critical for the optimal management of such patients.
Discussion
The main finding in this study was that CWH with
PAN (AN69®) filters lowered factor D levels very
significantly, producing in some patients a state of
factor D depletion. Removal of factor D was mainly
due to adsorption to the PAN membrane, a mechanism
which remained efficient for several hours.
Complement activation has been shown to particip-
ate in the pathogenesis of sepsis and ARDS and to
retard the resolution of ischemic renal failure.
Conversely, complement blockade or depletion was
beneficial in different animal models of sepsis-ARDS,
and dialysis with PAN (as opposed to cuprophane)
was associated with faster recovery from ARF in the
rate [6,7,8]. In vivo, a specific blockade of factor D
activity inhibits complement activation by the alternat-
ive pathway [9]. PAN membranes both inhibit comple-
ment activation at the blood-membrane interface and
deplete factor D from plasma [1]. Thus, the adsorption
of factor D by PAN membranes may be beneficial in
critically ill patients requiring dialysis [2], inspite of a
possible increased risk of infection due to alternative
pathway inhibition.
In addition, lowering complement activation with
PAN membranes may decrease the production of cyto-
kines in these patients, since complement products
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